Maze Therapeutics MAZE
NASDAQ MAZE
$36.40 +0.95 (+2.68%)
As of: Nov 11, 2026 · 9:51 AM EST

Maze Therapeutics (MAZE) Interest Coverage Ratio (2026)

Updated

Maze Therapeutics' (MAZE) Interest Coverage Ratio came in at -51.60 for Q2 2026.

Analysis

Maze Therapeutics (MAZE) Interest Coverage Ratio (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 28.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.20
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 5.68
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.87
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Maze Therapeutics 2.00 Bn 506.07 Mn - -52.84
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -52.84
Jun 30, 2026 -51.60
Mar 31, 2026 -30.66
API Access

Maze Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=MAZE&period=max&api_key=YOUR_API_KEY